Skip to main content


single-use bioprocessing market is expected to reach USD 20.8 billion by 2026 from USD 8.2 billion in 2021, at a CAGR of 20.5% during the forecast period. The growth in this market is attributed to the increasing demand for low-cost biopharmaceuticals, as single-use bioprocessing systems play a significant role in reducing the initial investments and R&D costs involved in the manufacturing process of biologics.